Q&A: New Novartis Dx President Discusses Nucleic Acid Testing, Blood Screening Business
March 15, 2012
Q&A: New Novartis Dx President Discusses Nucleic Acid Testing, Blood Screening Business
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Data Show Novartis/Gen-Probe Test Curbs HIV, HBV Transmission in South African Blood Supply
July 28, 2011 / PCR Insider - NEJM Study of Gen-Probe Assay Backs Use of Triplex NAT in HBV Blood Screening
January 20, 2011 / PCR Insider - PerkinElmer Buys Shanghai Haoyuan for Near-Term Blood Screening Play, Longer Term MDx Initiative
November 15, 2012 / PCR Insider - Hologic's Gen-Probe Wins Judgment in IP Suit Against BD, but Dispute Remain Unresolved
October 4, 2012 / PCR Insider - Gen-Probe to Serve as 'Cornerstone' of Hologic's MDx Franchise, Primarily Through STD Test Offerings
May 3, 2012 / PCR Insider